No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Late cranial neuropathy incidence may increase with time among oropharyngeal squamous cell carcinoma survivors

byTeddy Guo

April 1, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract TOURMALINE-MM2 trial: Oral ixazomib, lenalidomide, and dexamethasone is a feasible and well-tolerated all-oral regimen in non-transplant, newly diagnosed multiple myeloma

RelatedReports

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Gastric bypass surgery reduces cardio-metabolic risk factors

Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

Shorter time to angioplasty may improve heart attack outcomes

ST-elevation myocardial infarctions in the absence of standard modifiable cardiovascular risk factors may have worse outcomes

Increased mortality among parents of children with major congenital anomalies

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

P2Y12 inhibitor monotherapy after coronary stenting

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports